Presumably, HDAC deregulation in cancer promotes alterations in coordinated transcriptional programs that control key cellular processes, such as cell proliferation, apoptosis, tumor metabolism and immunogenicity [17]. The gene discussed is HDAC9; the disease is neoplasm.